Eric Easom - May 15, 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Easom
Stock symbol
ANTX
Transactions as of
May 15, 2023
Transactions value $
$53,770
Form type
4
Date filed
5/15/2023, 08:01 PM
Previous filing
Feb 24, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $53.8K +10K +0.99% $5.38 1.02M May 15, 2023 See Footnote F1
holding ANTX Common Stock 4.91K May 15, 2023 Direct
holding ANTX Common Stock 97.1K May 15, 2023 See Footnote F2
holding ANTX Common Stock 97.1K May 15, 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
F2 Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
F3 Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.